Cardiology

Published on December 12, the American Heart Association's scientific statement on diagnosis and management of acute coronary syndromes in older adults provides a review of several important topics including physiological changes, the influence of common geriatric syndromes, and age-appropriate and guideline-concordant recommendations for this patient population.

Drs Erin Michos, Pam Taub, Robert Busch, Alison Bailey, and Jorge Plutzky offer key takeaways in the management of hypercholesterolemia and ASCVD.

An expert panel discusses challenges and provides solutions to managing patients with hypercholesterolemia.

Our latest case report features a woman in her mid-70s presenting to the hospital with lightheadedness that came on gradually during brunch. Check out the ECG and determine the correct diagnosis!

They also found no statistically significant associations found for specific cardiovascular outcomes in relation to cardiac arrest or arrhythmias, cerebrovascular diseases, or myocardial infarction.

Our panel highlights the importance of a team-based approach to care in the management of hypercholesterolemia.

Erin D. Michos, MHS, FACC, FASPC; Pam Taub, MD, FACC, FASPC; Robert Busch, MD; Alison Bailey, MD, FACC; and Jorge Plutzky, MD; provide an overview of upcoming treatment options for managing hypercholesterolemia.

Gregory Weiss, MD, provides insight into his perspective on the evolving recognition of the role of sleep health in cardiovascular disease prevention.

A cluster randomized trial from Penn Medicine's Nudge Unit provides insight into the effects of "nudges" in primary care settings for improving the prescription of statins.

Leveraging data from the DASH trial, investigators from Beth Israel Deaconess Medical Center provides insight into the impact of different dietary approaches on 10-year ASCVD risk score among patients within the trial.

An analysis of data from patients admitted to emergency departments from 7 hospitals in Sweden provide insight into the potential of blood glucose at admission for use as a biomarker to predict all-cause mortality and cardiovascular risk in patients without a history of diabetes.

An analysis of self-reported dietary information from UK Biobank participants is providing insight into the effects of reducing added salt to foods on cardiovascular disease risk among adults without a history cardiovascular disease.

This case report features a patient in their mid-70s with a history of hypertension is brought in with chest pain radiating to both shoulders along with nausea and mild shortness of breath. Check out the full case report and determine the correct diagnosis!

An analysis of more than 800k women in Canada provides insight into the apparent increase in risk of incident cardiovascular disease associated with co-occurrence of gestational diabetes and gestational hypertensive disorders in pregnant women.

Erin D. Michos, MHS, FACC, FASPC; Pam Taub, MD, FACC, FASPC; Robert Busch, MD; Alison Bailey, MD, FACC; and Jorge Plutzky, MD; share benefits of combination therapy for lipid lowering in ASCVD and hypercholesterolemia.

A panel of experts discusses recommendations for managing statin intolerance in patients with hypercholesterolemia.

An analysis of data from 2010-2019 collected from 10 countries suggests influenza activity is responsible for 299k ischemic heart disease deaths per year on a global level.

Pam Taub, MD, FACC, FASPC, shares her thoughts on use of coronary artery calcium (CAC) scores when treating patients with nonstatin therapies.

Drs Erin Michos, Pam Taub, Robert Busch, Alison Bailey, and Jorge Plutzky review guidelines and recommendations for using lipid-lowering agents in addition to statins.

Announced in a statement on November 17, the US FDA issued letters to 7 companies related to unsupported claims of supplements being able to cure, treat, mitigate or prevent cardiovascular disease or related conditions, such as atherosclerosis, stroke or heart failure, in violation of the Federal Food, Drug, and Cosmetic Act.

An analysis of more than 8 million live singleton births in Nordic countries is providing insight into the impact of maternal preeclampsia on risk of ischemic heart disease and stroke in offspring during childhood and young adulthood.

Data from the ATLAS trial indicate use of a subcutaneous ICD was associated with a 92% reduction in lead-related complications compared to TV-ICD without compromising the effectiveness of shocks, but investigators express caution over an increased incidence of inappropriate shocks with the S-ICD.

Our editorial team has compiled a list of the top data and news from the American Heart Association 2022 Scientific Sessions, with a focus on heart failure, hypertension, and lipid management.

An expert panel reviews less frequently used lipid-lowering agents in hypercholesterolemia.

A panel of experts discusses use of bempedoic acid to manage hypercholesterolemia and data with bempedoic acid in combination with other lipid-lowering agents.